Distinct virtual histology of grey matter atrophy in four neuroinflammatory diseases

Grey matter (GM) atrophies are observed in multiple sclerosis, neuromyelitis optica spectrum disorders [NMOSD; both anti-aquaporin-4 antibody-positive (AQP4+) and -negative (AQP4-) subtypes] and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Revealing the pathogenesis of br...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain (London, England : 1878) England : 1878), 2024-11, Vol.147 (11), p.3906-3917
Hauptverfasser: Sun, Jun, Guo, Min, Chai, Li, Xu, Siyao, Lizhu, Yuerong, Li, Yuna, Duan, Yunyun, Xu, Xiaolu, Lv, Shan, Weng, Jinyuan, Li, Kuncheng, Zhou, Fuqing, Li, Haiqing, Li, Yongmei, Han, Xuemei, Shi, Fu-Dong, Zhang, Xinghu, Tian, De-Cai, Zhuo, Zhizheng, Liu, Yaou
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3917
container_issue 11
container_start_page 3906
container_title Brain (London, England : 1878)
container_volume 147
creator Sun, Jun
Guo, Min
Chai, Li
Xu, Siyao
Lizhu, Yuerong
Li, Yuna
Duan, Yunyun
Xu, Xiaolu
Lv, Shan
Weng, Jinyuan
Li, Kuncheng
Zhou, Fuqing
Li, Haiqing
Li, Yongmei
Han, Xuemei
Shi, Fu-Dong
Zhang, Xinghu
Tian, De-Cai
Zhuo, Zhizheng
Liu, Yaou
description Grey matter (GM) atrophies are observed in multiple sclerosis, neuromyelitis optica spectrum disorders [NMOSD; both anti-aquaporin-4 antibody-positive (AQP4+) and -negative (AQP4-) subtypes] and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Revealing the pathogenesis of brain atrophy in these disorders would help their differential diagnosis and guide therapeutic strategies. To determine the neurobiological underpinnings of GM atrophies in multiple sclerosis, AQP4+ NMOSD, AQP4- NMOSD and MOGAD, we conducted a virtual histology analysis that links T1-weighted image derived GM atrophy and gene expression using a multicentre cohort of 324 patients with multiple sclerosis, 197 patients with AQP4+ NMOSD, 75 patients with AQP4- NMOSD, 47 patients with MOGAD and 2169 healthy control subjects. First, interregional GM atrophy profiles across the cortical and subcortical regions were determined using Cohen's d between patients with multiple sclerosis, AQP4+ NMOSD, AQP4- NMOSD or MOGAD and healthy controls. The GM atrophy profiles were then spatially correlated with the gene expression levels extracted from the Allen Human Brain Atlas, respectively. Finally, we explored the virtual histology of clinical-feature relevant GM atrophy using a subgroup analysis that stratified by physical disability, disease duration, number of relapses, lesion burden and cognitive function. Multiple sclerosis showed a severe widespread GM atrophy pattern, mainly involving subcortical nuclei and brainstem. AQP4+ NMOSD showed an obvious widespread pattern of GM atrophy, predominately located in occipital cortex as well as cerebellum. AQP4- NMOSD showed a mild widespread GM atrophy pattern, mainly located in frontal and parietal cortices. MOGAD showed GM atrophy mainly involving the frontal and temporal cortices. High expression of genes specific to microglia, astrocytes, oligodendrocytes and endothelial cells in multiple sclerosis, S1 pyramidal cells in AQP4+ NMOSD, as well as S1 and CA1 pyramidal cells in MOGAD, had spatial correlations with GM atrophy profile, while no atrophy profile-related gene expression was found in AQP4- NMOSD. Virtual histology of clinical feature-relevant GM atrophy pointed mainly to the shared neuronal and endothelial cells, among the four neuroinflammatory diseases. The unique underlying virtual histology patterns were microglia, astrocytes and oligodendrocytes for multiple sclerosis; astrocytes for AQP4+ NMOSD; and oligodendrocytes f
doi_str_mv 10.1093/brain/awae138
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3050942737</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3050942737</sourcerecordid><originalsourceid>FETCH-LOGICAL-c179t-b8d0b6817fe5f33f6832b2b740069f32495f6acd71867ac5b21edfe08d99b4083</originalsourceid><addsrcrecordid>eNo9kDtPwzAYRS0EoqUwsiKPLIHPceLHiMpTqsRS5shO7NYoiYvtgPLvCbQwXenq6OrqIHRJ4IaApLc6KNffqi9lCBVHaE4KBllOSnaM5gDAMiFLmKGzGN8BSEFzdopmVHCglMMcre9dTK6vE_50IQ2qxdup8K3fjNhbvAlmxJ1KyQSsUvC77Yhdj60fAu7NELzrbau6ifBhxI2LRkUTz9GJVW00F4dcoLfHh_XyOVu9Pr0s71ZZTbhMmRYNaCYIt6a0lFomaK5zzYvptrQ0L2RpmaobTgTjqi51TkxjDYhGSl2AoAt0vd_dBf8xmJiqzsXatK3qjR9iRaEEWeSc8gnN9mgdfIzB2GoXXKfCWBGofkRWvyKrg8iJvzpMD7ozzT_9Z45-AxXKchM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3050942737</pqid></control><display><type>article</type><title>Distinct virtual histology of grey matter atrophy in four neuroinflammatory diseases</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Sun, Jun ; Guo, Min ; Chai, Li ; Xu, Siyao ; Lizhu, Yuerong ; Li, Yuna ; Duan, Yunyun ; Xu, Xiaolu ; Lv, Shan ; Weng, Jinyuan ; Li, Kuncheng ; Zhou, Fuqing ; Li, Haiqing ; Li, Yongmei ; Han, Xuemei ; Shi, Fu-Dong ; Zhang, Xinghu ; Tian, De-Cai ; Zhuo, Zhizheng ; Liu, Yaou</creator><creatorcontrib>Sun, Jun ; Guo, Min ; Chai, Li ; Xu, Siyao ; Lizhu, Yuerong ; Li, Yuna ; Duan, Yunyun ; Xu, Xiaolu ; Lv, Shan ; Weng, Jinyuan ; Li, Kuncheng ; Zhou, Fuqing ; Li, Haiqing ; Li, Yongmei ; Han, Xuemei ; Shi, Fu-Dong ; Zhang, Xinghu ; Tian, De-Cai ; Zhuo, Zhizheng ; Liu, Yaou</creatorcontrib><description>Grey matter (GM) atrophies are observed in multiple sclerosis, neuromyelitis optica spectrum disorders [NMOSD; both anti-aquaporin-4 antibody-positive (AQP4+) and -negative (AQP4-) subtypes] and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Revealing the pathogenesis of brain atrophy in these disorders would help their differential diagnosis and guide therapeutic strategies. To determine the neurobiological underpinnings of GM atrophies in multiple sclerosis, AQP4+ NMOSD, AQP4- NMOSD and MOGAD, we conducted a virtual histology analysis that links T1-weighted image derived GM atrophy and gene expression using a multicentre cohort of 324 patients with multiple sclerosis, 197 patients with AQP4+ NMOSD, 75 patients with AQP4- NMOSD, 47 patients with MOGAD and 2169 healthy control subjects. First, interregional GM atrophy profiles across the cortical and subcortical regions were determined using Cohen's d between patients with multiple sclerosis, AQP4+ NMOSD, AQP4- NMOSD or MOGAD and healthy controls. The GM atrophy profiles were then spatially correlated with the gene expression levels extracted from the Allen Human Brain Atlas, respectively. Finally, we explored the virtual histology of clinical-feature relevant GM atrophy using a subgroup analysis that stratified by physical disability, disease duration, number of relapses, lesion burden and cognitive function. Multiple sclerosis showed a severe widespread GM atrophy pattern, mainly involving subcortical nuclei and brainstem. AQP4+ NMOSD showed an obvious widespread pattern of GM atrophy, predominately located in occipital cortex as well as cerebellum. AQP4- NMOSD showed a mild widespread GM atrophy pattern, mainly located in frontal and parietal cortices. MOGAD showed GM atrophy mainly involving the frontal and temporal cortices. High expression of genes specific to microglia, astrocytes, oligodendrocytes and endothelial cells in multiple sclerosis, S1 pyramidal cells in AQP4+ NMOSD, as well as S1 and CA1 pyramidal cells in MOGAD, had spatial correlations with GM atrophy profile, while no atrophy profile-related gene expression was found in AQP4- NMOSD. Virtual histology of clinical feature-relevant GM atrophy pointed mainly to the shared neuronal and endothelial cells, among the four neuroinflammatory diseases. The unique underlying virtual histology patterns were microglia, astrocytes and oligodendrocytes for multiple sclerosis; astrocytes for AQP4+ NMOSD; and oligodendrocytes for MOGAD. Neuronal and endothelial cells were shared potential targets across these neuroinflammatory diseases. These findings may help the differential diagnoses of these diseases and promote the use of optimal therapeutic strategies.</description><identifier>ISSN: 0006-8950</identifier><identifier>ISSN: 1460-2156</identifier><identifier>EISSN: 1460-2156</identifier><identifier>DOI: 10.1093/brain/awae138</identifier><identifier>PMID: 38703370</identifier><language>eng</language><publisher>England</publisher><subject>Adult ; Aged ; Aquaporin 4 ; Atrophy - pathology ; Brain - pathology ; Female ; Gray Matter - diagnostic imaging ; Gray Matter - pathology ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Multiple Sclerosis - diagnostic imaging ; Multiple Sclerosis - pathology ; Myelin-Oligodendrocyte Glycoprotein ; Neuroinflammatory Diseases - pathology ; Neuromyelitis Optica - genetics ; Neuromyelitis Optica - pathology</subject><ispartof>Brain (London, England : 1878), 2024-11, Vol.147 (11), p.3906-3917</ispartof><rights>The Author(s) 2024. Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c179t-b8d0b6817fe5f33f6832b2b740069f32495f6acd71867ac5b21edfe08d99b4083</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38703370$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sun, Jun</creatorcontrib><creatorcontrib>Guo, Min</creatorcontrib><creatorcontrib>Chai, Li</creatorcontrib><creatorcontrib>Xu, Siyao</creatorcontrib><creatorcontrib>Lizhu, Yuerong</creatorcontrib><creatorcontrib>Li, Yuna</creatorcontrib><creatorcontrib>Duan, Yunyun</creatorcontrib><creatorcontrib>Xu, Xiaolu</creatorcontrib><creatorcontrib>Lv, Shan</creatorcontrib><creatorcontrib>Weng, Jinyuan</creatorcontrib><creatorcontrib>Li, Kuncheng</creatorcontrib><creatorcontrib>Zhou, Fuqing</creatorcontrib><creatorcontrib>Li, Haiqing</creatorcontrib><creatorcontrib>Li, Yongmei</creatorcontrib><creatorcontrib>Han, Xuemei</creatorcontrib><creatorcontrib>Shi, Fu-Dong</creatorcontrib><creatorcontrib>Zhang, Xinghu</creatorcontrib><creatorcontrib>Tian, De-Cai</creatorcontrib><creatorcontrib>Zhuo, Zhizheng</creatorcontrib><creatorcontrib>Liu, Yaou</creatorcontrib><title>Distinct virtual histology of grey matter atrophy in four neuroinflammatory diseases</title><title>Brain (London, England : 1878)</title><addtitle>Brain</addtitle><description>Grey matter (GM) atrophies are observed in multiple sclerosis, neuromyelitis optica spectrum disorders [NMOSD; both anti-aquaporin-4 antibody-positive (AQP4+) and -negative (AQP4-) subtypes] and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Revealing the pathogenesis of brain atrophy in these disorders would help their differential diagnosis and guide therapeutic strategies. To determine the neurobiological underpinnings of GM atrophies in multiple sclerosis, AQP4+ NMOSD, AQP4- NMOSD and MOGAD, we conducted a virtual histology analysis that links T1-weighted image derived GM atrophy and gene expression using a multicentre cohort of 324 patients with multiple sclerosis, 197 patients with AQP4+ NMOSD, 75 patients with AQP4- NMOSD, 47 patients with MOGAD and 2169 healthy control subjects. First, interregional GM atrophy profiles across the cortical and subcortical regions were determined using Cohen's d between patients with multiple sclerosis, AQP4+ NMOSD, AQP4- NMOSD or MOGAD and healthy controls. The GM atrophy profiles were then spatially correlated with the gene expression levels extracted from the Allen Human Brain Atlas, respectively. Finally, we explored the virtual histology of clinical-feature relevant GM atrophy using a subgroup analysis that stratified by physical disability, disease duration, number of relapses, lesion burden and cognitive function. Multiple sclerosis showed a severe widespread GM atrophy pattern, mainly involving subcortical nuclei and brainstem. AQP4+ NMOSD showed an obvious widespread pattern of GM atrophy, predominately located in occipital cortex as well as cerebellum. AQP4- NMOSD showed a mild widespread GM atrophy pattern, mainly located in frontal and parietal cortices. MOGAD showed GM atrophy mainly involving the frontal and temporal cortices. High expression of genes specific to microglia, astrocytes, oligodendrocytes and endothelial cells in multiple sclerosis, S1 pyramidal cells in AQP4+ NMOSD, as well as S1 and CA1 pyramidal cells in MOGAD, had spatial correlations with GM atrophy profile, while no atrophy profile-related gene expression was found in AQP4- NMOSD. Virtual histology of clinical feature-relevant GM atrophy pointed mainly to the shared neuronal and endothelial cells, among the four neuroinflammatory diseases. The unique underlying virtual histology patterns were microglia, astrocytes and oligodendrocytes for multiple sclerosis; astrocytes for AQP4+ NMOSD; and oligodendrocytes for MOGAD. Neuronal and endothelial cells were shared potential targets across these neuroinflammatory diseases. These findings may help the differential diagnoses of these diseases and promote the use of optimal therapeutic strategies.</description><subject>Adult</subject><subject>Aged</subject><subject>Aquaporin 4</subject><subject>Atrophy - pathology</subject><subject>Brain - pathology</subject><subject>Female</subject><subject>Gray Matter - diagnostic imaging</subject><subject>Gray Matter - pathology</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multiple Sclerosis - diagnostic imaging</subject><subject>Multiple Sclerosis - pathology</subject><subject>Myelin-Oligodendrocyte Glycoprotein</subject><subject>Neuroinflammatory Diseases - pathology</subject><subject>Neuromyelitis Optica - genetics</subject><subject>Neuromyelitis Optica - pathology</subject><issn>0006-8950</issn><issn>1460-2156</issn><issn>1460-2156</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kDtPwzAYRS0EoqUwsiKPLIHPceLHiMpTqsRS5shO7NYoiYvtgPLvCbQwXenq6OrqIHRJ4IaApLc6KNffqi9lCBVHaE4KBllOSnaM5gDAMiFLmKGzGN8BSEFzdopmVHCglMMcre9dTK6vE_50IQ2qxdup8K3fjNhbvAlmxJ1KyQSsUvC77Yhdj60fAu7NELzrbau6ifBhxI2LRkUTz9GJVW00F4dcoLfHh_XyOVu9Pr0s71ZZTbhMmRYNaCYIt6a0lFomaK5zzYvptrQ0L2RpmaobTgTjqi51TkxjDYhGSl2AoAt0vd_dBf8xmJiqzsXatK3qjR9iRaEEWeSc8gnN9mgdfIzB2GoXXKfCWBGofkRWvyKrg8iJvzpMD7ozzT_9Z45-AxXKchM</recordid><startdate>20241104</startdate><enddate>20241104</enddate><creator>Sun, Jun</creator><creator>Guo, Min</creator><creator>Chai, Li</creator><creator>Xu, Siyao</creator><creator>Lizhu, Yuerong</creator><creator>Li, Yuna</creator><creator>Duan, Yunyun</creator><creator>Xu, Xiaolu</creator><creator>Lv, Shan</creator><creator>Weng, Jinyuan</creator><creator>Li, Kuncheng</creator><creator>Zhou, Fuqing</creator><creator>Li, Haiqing</creator><creator>Li, Yongmei</creator><creator>Han, Xuemei</creator><creator>Shi, Fu-Dong</creator><creator>Zhang, Xinghu</creator><creator>Tian, De-Cai</creator><creator>Zhuo, Zhizheng</creator><creator>Liu, Yaou</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20241104</creationdate><title>Distinct virtual histology of grey matter atrophy in four neuroinflammatory diseases</title><author>Sun, Jun ; Guo, Min ; Chai, Li ; Xu, Siyao ; Lizhu, Yuerong ; Li, Yuna ; Duan, Yunyun ; Xu, Xiaolu ; Lv, Shan ; Weng, Jinyuan ; Li, Kuncheng ; Zhou, Fuqing ; Li, Haiqing ; Li, Yongmei ; Han, Xuemei ; Shi, Fu-Dong ; Zhang, Xinghu ; Tian, De-Cai ; Zhuo, Zhizheng ; Liu, Yaou</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c179t-b8d0b6817fe5f33f6832b2b740069f32495f6acd71867ac5b21edfe08d99b4083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aquaporin 4</topic><topic>Atrophy - pathology</topic><topic>Brain - pathology</topic><topic>Female</topic><topic>Gray Matter - diagnostic imaging</topic><topic>Gray Matter - pathology</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multiple Sclerosis - diagnostic imaging</topic><topic>Multiple Sclerosis - pathology</topic><topic>Myelin-Oligodendrocyte Glycoprotein</topic><topic>Neuroinflammatory Diseases - pathology</topic><topic>Neuromyelitis Optica - genetics</topic><topic>Neuromyelitis Optica - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sun, Jun</creatorcontrib><creatorcontrib>Guo, Min</creatorcontrib><creatorcontrib>Chai, Li</creatorcontrib><creatorcontrib>Xu, Siyao</creatorcontrib><creatorcontrib>Lizhu, Yuerong</creatorcontrib><creatorcontrib>Li, Yuna</creatorcontrib><creatorcontrib>Duan, Yunyun</creatorcontrib><creatorcontrib>Xu, Xiaolu</creatorcontrib><creatorcontrib>Lv, Shan</creatorcontrib><creatorcontrib>Weng, Jinyuan</creatorcontrib><creatorcontrib>Li, Kuncheng</creatorcontrib><creatorcontrib>Zhou, Fuqing</creatorcontrib><creatorcontrib>Li, Haiqing</creatorcontrib><creatorcontrib>Li, Yongmei</creatorcontrib><creatorcontrib>Han, Xuemei</creatorcontrib><creatorcontrib>Shi, Fu-Dong</creatorcontrib><creatorcontrib>Zhang, Xinghu</creatorcontrib><creatorcontrib>Tian, De-Cai</creatorcontrib><creatorcontrib>Zhuo, Zhizheng</creatorcontrib><creatorcontrib>Liu, Yaou</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Brain (London, England : 1878)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sun, Jun</au><au>Guo, Min</au><au>Chai, Li</au><au>Xu, Siyao</au><au>Lizhu, Yuerong</au><au>Li, Yuna</au><au>Duan, Yunyun</au><au>Xu, Xiaolu</au><au>Lv, Shan</au><au>Weng, Jinyuan</au><au>Li, Kuncheng</au><au>Zhou, Fuqing</au><au>Li, Haiqing</au><au>Li, Yongmei</au><au>Han, Xuemei</au><au>Shi, Fu-Dong</au><au>Zhang, Xinghu</au><au>Tian, De-Cai</au><au>Zhuo, Zhizheng</au><au>Liu, Yaou</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Distinct virtual histology of grey matter atrophy in four neuroinflammatory diseases</atitle><jtitle>Brain (London, England : 1878)</jtitle><addtitle>Brain</addtitle><date>2024-11-04</date><risdate>2024</risdate><volume>147</volume><issue>11</issue><spage>3906</spage><epage>3917</epage><pages>3906-3917</pages><issn>0006-8950</issn><issn>1460-2156</issn><eissn>1460-2156</eissn><abstract>Grey matter (GM) atrophies are observed in multiple sclerosis, neuromyelitis optica spectrum disorders [NMOSD; both anti-aquaporin-4 antibody-positive (AQP4+) and -negative (AQP4-) subtypes] and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Revealing the pathogenesis of brain atrophy in these disorders would help their differential diagnosis and guide therapeutic strategies. To determine the neurobiological underpinnings of GM atrophies in multiple sclerosis, AQP4+ NMOSD, AQP4- NMOSD and MOGAD, we conducted a virtual histology analysis that links T1-weighted image derived GM atrophy and gene expression using a multicentre cohort of 324 patients with multiple sclerosis, 197 patients with AQP4+ NMOSD, 75 patients with AQP4- NMOSD, 47 patients with MOGAD and 2169 healthy control subjects. First, interregional GM atrophy profiles across the cortical and subcortical regions were determined using Cohen's d between patients with multiple sclerosis, AQP4+ NMOSD, AQP4- NMOSD or MOGAD and healthy controls. The GM atrophy profiles were then spatially correlated with the gene expression levels extracted from the Allen Human Brain Atlas, respectively. Finally, we explored the virtual histology of clinical-feature relevant GM atrophy using a subgroup analysis that stratified by physical disability, disease duration, number of relapses, lesion burden and cognitive function. Multiple sclerosis showed a severe widespread GM atrophy pattern, mainly involving subcortical nuclei and brainstem. AQP4+ NMOSD showed an obvious widespread pattern of GM atrophy, predominately located in occipital cortex as well as cerebellum. AQP4- NMOSD showed a mild widespread GM atrophy pattern, mainly located in frontal and parietal cortices. MOGAD showed GM atrophy mainly involving the frontal and temporal cortices. High expression of genes specific to microglia, astrocytes, oligodendrocytes and endothelial cells in multiple sclerosis, S1 pyramidal cells in AQP4+ NMOSD, as well as S1 and CA1 pyramidal cells in MOGAD, had spatial correlations with GM atrophy profile, while no atrophy profile-related gene expression was found in AQP4- NMOSD. Virtual histology of clinical feature-relevant GM atrophy pointed mainly to the shared neuronal and endothelial cells, among the four neuroinflammatory diseases. The unique underlying virtual histology patterns were microglia, astrocytes and oligodendrocytes for multiple sclerosis; astrocytes for AQP4+ NMOSD; and oligodendrocytes for MOGAD. Neuronal and endothelial cells were shared potential targets across these neuroinflammatory diseases. These findings may help the differential diagnoses of these diseases and promote the use of optimal therapeutic strategies.</abstract><cop>England</cop><pmid>38703370</pmid><doi>10.1093/brain/awae138</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-8950
ispartof Brain (London, England : 1878), 2024-11, Vol.147 (11), p.3906-3917
issn 0006-8950
1460-2156
1460-2156
language eng
recordid cdi_proquest_miscellaneous_3050942737
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; Alma/SFX Local Collection
subjects Adult
Aged
Aquaporin 4
Atrophy - pathology
Brain - pathology
Female
Gray Matter - diagnostic imaging
Gray Matter - pathology
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Multiple Sclerosis - diagnostic imaging
Multiple Sclerosis - pathology
Myelin-Oligodendrocyte Glycoprotein
Neuroinflammatory Diseases - pathology
Neuromyelitis Optica - genetics
Neuromyelitis Optica - pathology
title Distinct virtual histology of grey matter atrophy in four neuroinflammatory diseases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T05%3A12%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Distinct%20virtual%20histology%20of%20grey%20matter%20atrophy%20in%20four%20neuroinflammatory%20diseases&rft.jtitle=Brain%20(London,%20England%20:%201878)&rft.au=Sun,%20Jun&rft.date=2024-11-04&rft.volume=147&rft.issue=11&rft.spage=3906&rft.epage=3917&rft.pages=3906-3917&rft.issn=0006-8950&rft.eissn=1460-2156&rft_id=info:doi/10.1093/brain/awae138&rft_dat=%3Cproquest_cross%3E3050942737%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3050942737&rft_id=info:pmid/38703370&rfr_iscdi=true